Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Is it Time to Cash Out Novavax Stock?
01:00am, Tuesday, 19'th Jul 2022
Vaccine developer Novavax (NASDAQ: NVAX) stock has collapsed (-61%) in 2022. The Company's protein-based COVID-19 vaccine Nuvaxovid has launched in Europe and awaits CDC approval for launch the U.S.
Novavax (NVAX) Soars 5.4%: Is Further Upside Left in the Stock?
07:44am, Monday, 18'th Jul 2022
Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
After a 26% Drop, Should You Give Up on Novavax?
06:00am, Monday, 18'th Jul 2022
The shares are down -- but revenue and profit are on the rise.
3 Monster Growth Stocks That Can Turn $350,000 Into $1 Million by 2028
05:06am, Sunday, 17'th Jul 2022
These supercharged growth stocks have the tools and intangibles necessary to make patient investors a lot richer.
What You Should Know About Novavax
04:00pm, Friday, 15'th Jul 2022
The FDA has authorized a new COVID vaccine, and the CDC will decide soon how it'll roll out. Here's what to know.
Novavax: EUA Win A Cause To Celebrate Despite Anaphylaxis Warning
01:18pm, Friday, 15'th Jul 2022
Novavax finally secured its EUA from the FDA this week. Its COVID vaccine becomes the fourth authorized in the US.
Is Novavax (NVAX) Stock a Buy After FDA Decision?
12:47pm, Friday, 15'th Jul 2022
Novavax (NVAX) stock is in the spotlight on Friday as investors react to recent FDA news concerning its Covid-19 vaccine. The post Is Novavax (NVAX) Stock a Buy After FDA Decision?
10 Reasons To Buy The Novavax Slaughterfest
12:04pm, Friday, 15'th Jul 2022
FDA finally granted Emergency Use Authorization to Novavax's Covid-19 vaccine. The classic sell-the-news scenario paired with an overseas label change might have created the perfect entrance point for
Novavax (NVAX) Down as EU Adds Side Effects to COVID Jab Label
09:52am, Friday, 15'th Jul 2022
The administration of Novavax's (NVAX) COVID-19 vaccine leads to some cases of severe allergic reactions as well as skin problems, per a safety update issued by the EMA.
Novavax's Vaccine Won U.S. Authorization: 5 Reasons Why Its Stock Still Crashed
05:51am, Friday, 15'th Jul 2022
Stocks usually soar on good news. But there were some complicating factors for Novavax.
Yesterday Was Big for Tech Stocks
10:45pm, Thursday, 14'th Jul 2022
Tech stocks hold up in spite of horrific economic news
5 Stocks to Outrun the Housing Market
05:44pm, Thursday, 14'th Jul 2022
If you're looking to buy a piece of the real estate market without the risk, these 5 real estate stocks to buy are set to outrun the market. The post 5 Stocks to Outrun the Housing Market appeared fir
Novavax's (NVAX) Protein-Based COVID Jab Gets EUA in the US
12:24pm, Thursday, 14'th Jul 2022
Following the grant of emergency use authorization by the FDA, Novavax's (NVAX) COVID-19 vaccine is the first protein-based COVID vaccine authorized for use in the United States.
Novavax COVID vaccine gets EUA, Richard Branson backs trading platform, Tesla AI director departs,
11:59am, Thursday, 14'th Jul 2022
Yahoo Finance anchor Julie Hyman reports the latest business headlines include Novavax's COVID-19 vaccine receiving FDA authorization, Richard Branson financially backing European trading platform Lig
What Is Going on With Novavax (NVAX) Stock Today?
10:40am, Thursday, 14'th Jul 2022
NVAX stock is falling on news that European regulators have placed a new warning on the company's Covid-19 vaccine. The post What Is Going on With Novavax (NVAX) Stock Today?
